Heart Test Laboratories, Inc. (NASDAQ: HSCS) had its price target lowered by analysts at Maxim Group from $8.00 to $3.00.
Heart Test Laboratories, Inc. (HSCS)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
HSCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSCS alerts
High impacting Heart Test Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
HSCS
News
- HeartSciences to Present at the LD Micro Invitational XIV ConferenceGlobeNewswire
- HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients [Yahoo! Finance]Yahoo! Finance
- HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsGlobeNewswire
- Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- HeartSciences Reports Third Quarter Fiscal 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
HSCS
Sec Filings
- 3/18/24 - Form 424B3
- 3/14/24 - Form 8-K
- 3/14/24 - Form 10-Q
- HSCS's page on the SEC website